CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma
<p>Abstract</p> <p>Background</p> <p>Renal cell carcinoma (RCC) is histopathologically heterogeneous with clear cell and papillary the most common subtypes. The most frequent molecular abnormality in clear cell RCC is <it>VHL </it>inactivation but promoter m...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-06-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/8/1/31 |
id |
doaj-c34e7483d1224247ae2597f0fd2be8c5 |
---|---|
record_format |
Article |
spelling |
doaj-c34e7483d1224247ae2597f0fd2be8c52020-11-24T21:58:57ZengBMCMolecular Cancer1476-45982009-06-01813110.1186/1476-4598-8-31CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinomaClarke Noel WRagoussis JiannisBaban DilairWinchester LauraGentle DeanMorris Mark RMcRonald Fiona EBrown Michael DKishida TakeshiYao MasahiroLatif FaridaMaher Eamonn R<p>Abstract</p> <p>Background</p> <p>Renal cell carcinoma (RCC) is histopathologically heterogeneous with clear cell and papillary the most common subtypes. The most frequent molecular abnormality in clear cell RCC is <it>VHL </it>inactivation but promoter methylation of tumour suppressor genes is common in both subtypes of RCC. To investigate whether RCC CpG methylation status was influenced by histopathology and <it>VHL </it>status we performed high-throughput epigenetic profiling using the Illumina Goldengate Methylation Array in 62 RCC (29 RCC from von Hippel-Lindau (VHL) disease patients, 20 sporadic clear cell RCC with wild type VHL and 13 sporadic papillary RCC).</p> <p>Results</p> <p>43 genes were methylated in >20% of primary RCC (range 20–45%) and most (37/43) of these had not been reported previously to be methylated in RCC. The distribution of the number of methylated CpGs in individual tumours differed from the expected Poisson distribution (p < 0.00001; log-likelihood G test) suggesting that a subset of RCC displayed a CpG Island Methylator Phenotype. Comparison of RCC subtypes revealed that, on average, tumour specific CpG methylation was most prevalent in papillary RCC and least in VHL RCC. Many of the genes preferentially methylated in pRCC were linked to TGFβ or ERK/Akt signalling.</p> <p>Conclusion</p> <p>These findings demonstrate differing patterns of tumour-specific CpG methylation in VHL and non VHL clear cell RCC and papillary RCC, and identify multiple novel potential CpG methylation biomarkers for RCC.</p> http://www.molecular-cancer.com/content/8/1/31 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Clarke Noel W Ragoussis Jiannis Baban Dilair Winchester Laura Gentle Dean Morris Mark R McRonald Fiona E Brown Michael D Kishida Takeshi Yao Masahiro Latif Farida Maher Eamonn R |
spellingShingle |
Clarke Noel W Ragoussis Jiannis Baban Dilair Winchester Laura Gentle Dean Morris Mark R McRonald Fiona E Brown Michael D Kishida Takeshi Yao Masahiro Latif Farida Maher Eamonn R CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma Molecular Cancer |
author_facet |
Clarke Noel W Ragoussis Jiannis Baban Dilair Winchester Laura Gentle Dean Morris Mark R McRonald Fiona E Brown Michael D Kishida Takeshi Yao Masahiro Latif Farida Maher Eamonn R |
author_sort |
Clarke Noel W |
title |
CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma |
title_short |
CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma |
title_full |
CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma |
title_fullStr |
CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma |
title_full_unstemmed |
CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma |
title_sort |
cpg methylation profiling in <it>vhl </it>related and <it>vhl </it>unrelated renal cell carcinoma |
publisher |
BMC |
series |
Molecular Cancer |
issn |
1476-4598 |
publishDate |
2009-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Renal cell carcinoma (RCC) is histopathologically heterogeneous with clear cell and papillary the most common subtypes. The most frequent molecular abnormality in clear cell RCC is <it>VHL </it>inactivation but promoter methylation of tumour suppressor genes is common in both subtypes of RCC. To investigate whether RCC CpG methylation status was influenced by histopathology and <it>VHL </it>status we performed high-throughput epigenetic profiling using the Illumina Goldengate Methylation Array in 62 RCC (29 RCC from von Hippel-Lindau (VHL) disease patients, 20 sporadic clear cell RCC with wild type VHL and 13 sporadic papillary RCC).</p> <p>Results</p> <p>43 genes were methylated in >20% of primary RCC (range 20–45%) and most (37/43) of these had not been reported previously to be methylated in RCC. The distribution of the number of methylated CpGs in individual tumours differed from the expected Poisson distribution (p < 0.00001; log-likelihood G test) suggesting that a subset of RCC displayed a CpG Island Methylator Phenotype. Comparison of RCC subtypes revealed that, on average, tumour specific CpG methylation was most prevalent in papillary RCC and least in VHL RCC. Many of the genes preferentially methylated in pRCC were linked to TGFβ or ERK/Akt signalling.</p> <p>Conclusion</p> <p>These findings demonstrate differing patterns of tumour-specific CpG methylation in VHL and non VHL clear cell RCC and papillary RCC, and identify multiple novel potential CpG methylation biomarkers for RCC.</p> |
url |
http://www.molecular-cancer.com/content/8/1/31 |
work_keys_str_mv |
AT clarkenoelw cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT ragoussisjiannis cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT babandilair cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT winchesterlaura cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT gentledean cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT morrismarkr cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT mcronaldfionae cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT brownmichaeld cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT kishidatakeshi cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT yaomasahiro cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT latiffarida cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma AT mahereamonnr cpgmethylationprofilinginitvhlitrelatedanditvhlitunrelatedrenalcellcarcinoma |
_version_ |
1725850092087279616 |